Insufficient scRNA-seq data for expression of FBXO43 at single-cell level.
Insufficient scRNA-seq data for expression of FBXO43 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 94% | 55.03 | 1702 / 1809 | 61% | 1.44 | 287 / 472 |
uterus | 96% | 27.06 | 163 / 170 | 53% | 1.56 | 244 / 459 |
ovary | 94% | 26.55 | 169 / 180 | 30% | 0.63 | 129 / 430 |
esophagus | 77% | 12.93 | 1119 / 1445 | 46% | 1.02 | 84 / 183 |
breast | 81% | 15.07 | 374 / 459 | 38% | 0.82 | 428 / 1118 |
lung | 88% | 25.08 | 507 / 578 | 31% | 0.71 | 360 / 1155 |
liver | 74% | 17.15 | 168 / 226 | 38% | 0.86 | 154 / 406 |
bladder | 90% | 15.76 | 19 / 21 | 21% | 0.60 | 107 / 504 |
prostate | 97% | 30.77 | 237 / 245 | 7% | 0.11 | 35 / 502 |
brain | 83% | 13.77 | 2203 / 2642 | 19% | 0.44 | 135 / 705 |
thymus | 90% | 20.04 | 588 / 653 | 12% | 0.81 | 73 / 605 |
pancreas | 88% | 14.96 | 290 / 328 | 11% | 0.28 | 20 / 178 |
spleen | 99% | 50.48 | 239 / 241 | 0% | 0 | 0 / 0 |
stomach | 88% | 17.43 | 317 / 359 | 9% | 0.15 | 25 / 286 |
adrenal gland | 88% | 20.79 | 227 / 258 | 7% | 0.18 | 17 / 230 |
lymph node | 0% | 0 | 0 / 0 | 93% | 3.13 | 27 / 29 |
kidney | 85% | 17.88 | 76 / 89 | 6% | 0.12 | 52 / 901 |
intestine | 81% | 16.23 | 780 / 966 | 6% | 0.11 | 34 / 527 |
adipose | 71% | 13.28 | 853 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 2.18 | 31 / 45 |
blood vessel | 69% | 8.86 | 916 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 55% | 125.60 | 509 / 929 | 0% | 0 | 0 / 0 |
heart | 38% | 4.24 | 328 / 861 | 0% | 0 | 0 / 0 |
muscle | 26% | 2.37 | 205 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0045835 | Biological process | negative regulation of meiotic nuclear division |
GO_0010948 | Biological process | negative regulation of cell cycle process |
GO_0007088 | Biological process | regulation of mitotic nuclear division |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | FBXO43 |
Protein name | F-box protein 43 F-box only protein 43 (Endogenous meiotic inhibitor 2) |
Synonyms | EMI2 |
Description | FUNCTION: Required to establish and maintain the arrest of oocytes at the second meiotic metaphase until fertilization. Acts by inhibiting the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase. Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation . Plays a vital role in modulating the ubiquitilation of CCNB1 and CDK1 during gametogenesis. . |
Accessions | ENST00000517806.5 E5RHI5 Q4G163 ENST00000428847.3 |